Jay Bhattacharya Named Acting CDC Director: Leadership Changes at HHS
- Jay Bhattacharya, currently director of the National Institutes of Health (NIH), has been appointed as the acting director of the Centers for Disease Control and Prevention (CDC), effective...
- The transition at the CDC is part of a broader series of leadership changes within the Department of Health and Human Services (HHS).
- This latest change in leadership at the CDC comes after a period of significant turnover.
Dr. Jay Bhattacharya, currently director of the National Institutes of Health (NIH), has been appointed as the acting director of the Centers for Disease Control and Prevention (CDC), effective . This appointment follows the departure of Jim O’Neill, who had been serving as acting CDC director since August and HHS General Counsel Mike Stuart.
The transition at the CDC is part of a broader series of leadership changes within the Department of Health and Human Services (HHS). O’Neill and Stuart have both been offered other positions within the administration, according to an administration official. Bhattacharya will continue to fulfill his duties as NIH director while leading the CDC on an interim basis, pending a nomination from President Donald Trump for a permanent director.
This latest change in leadership at the CDC comes after a period of significant turnover. Former CDC Director Susan Monarez was removed from her position after just 29 days, citing disagreements with HHS Secretary Robert F. Kennedy Jr. Over vaccine guidance. Monarez testified before the Senate Committee on Health, Education, Labor and Pensions that she was dismissed for refusing to approve changes to vaccine recommendations without sufficient justification. Kennedy has disputed this account. Following Monarez’s departure, several senior CDC officials resigned in protest.
The instability extends beyond the CDC’s top position. In December, Martin Kulldorff, PhD, stepped down as chair of the CDC’s Advisory Committee on Immunization Practices. The NIH itself has experienced considerable staff changes, with more than half of its 27 institutes and centers currently lacking permanent directors due to a combination of terminations, resignations, and retirements.
Dr. Jeanne Marrazzo, who succeeded Dr. Anthony Fauci as director of the National Institute of Allergy and Infectious Diseases in 2023, was also terminated by Secretary Kennedy in September, reportedly due to her vocal support for vaccines and her opposition to the cancellation of NIH research projects.
Bhattacharya gained prominence during the COVID-19 pandemic for his views opposing widespread lockdowns. His appointment as acting CDC director signals a potential shift in the agency’s approach to public health measures. The personnel changes at HHS, as noted by a White House official in Politico, are intended to advance the administration’s health policy priorities leading up to the midterm elections.
The frequent leadership changes within key health agencies raise questions about the continuity and stability of public health initiatives. The CDC plays a critical role in protecting the nation from disease outbreaks, promoting health, and providing evidence-based guidance to healthcare professionals and the public. A spokesperson for the Department of Health and Human Services did not immediately respond to a request for comment regarding the ongoing leadership transitions.
The situation highlights the complex interplay between scientific expertise, political considerations, and public health policy. The CDC’s ability to effectively respond to emerging health threats and maintain public trust will depend, in part, on establishing a stable and experienced leadership team. The appointment of Dr. Bhattacharya, with his background at the NIH and his publicly stated views on pandemic response, represents a significant development in this ongoing process.